NeoGenomics
NEO
253 hedge funds and large institutions have $2.02B invested in NeoGenomics in 2024 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 78 increasing their positions, 96 reducing their positions, and 35 closing their positions.
789% more call options, than puts
Call options by funds: $15.6M | Put options by funds: $1.75M
11% more capital invested
Capital invested by funds: $1.82B → $2.02B (+$196M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
1.14% less ownership
Funds ownership: 96.7% → 95.56% (-1.1%)
6% less funds holding
Funds holding: 270 → 253 (-17)
19% less repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 96
34% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 35
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$21.5M |
| 2 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$9.08M |
| 3 |
BlackRock
New York
|
+$5.16M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$4.47M |
| 5 |
State Street
Boston,
Massachusetts
|
+$3.73M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Brown Advisory
Baltimore,
Maryland
|
-$11.4M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$9.05M |
| 3 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$8.65M |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$6.89M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$6.8M |
NEO Hedge Fund Activity: Q4 2024 in Review
253 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q4 2024, worth a combined $2.02B — up 11% from $1.82B a quarter earlier.
Sellers outnumbered buyers: 35 funds closed out of NEO and 23 opened new positions — a net loss of 12 holders — while 96 trimmed existing stakes and 78 added.
The largest buyer was Millennium Management, adding an estimated $21.5M. The largest seller was Brown Advisory, cutting an estimated $11.4M.
- 253 institutional investors held NeoGenomics (NEO) as of Q4 2024, down from 270 in Q3 2024.
- Funds reported $2.02B of NeoGenomics stock for Q4 2024, up 11% quarter-over-quarter.
- 23 funds opened new NeoGenomics positions in Q4 2024 and 35 closed out, a net change of -12 holders.
- The largest NeoGenomics buyer in Q4 2024 was Millennium Management, an estimated $21.5M added.
- The largest NeoGenomics seller in Q4 2024 was Brown Advisory, an estimated $11.4M sold.
Based on aggregated 13F filings for Q4 2024.